Potential predictors for survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: A meta-analysis

CONCLUSION: These results suggest that PFS could be potential surrogates for OS, especially PFS for patients who treated with ICI combination regimen.PMID:34530205 | DOI:10.1016/j.intimp.2021.108135

Source: International Immunopharmacology - September 16, 2021 Category: Allergy & Immunology Authors: Huilin Xu Dedong Cao Yongfa Zheng Dingjie Zhou Xin Chen Jinju Lei Wei Ge Ximing Xu Source Type: research